It is used in people with diabetes to control high blood sugar, but it does not directly affect appetite or weight loss
More and more small businesses are turning to ICHRA as an affordable, flexible health benefit solution
The series, authored by RWJF Senior Policy Adviser Katherine Hempstead, analyzes changes in the individual market
This often involves combining a proven methodology, in this case, semaglutide injections, with a healthy diet, exercise, and lifestyle changes to create a realistic, achievable plan
The initiative aims to provide more affordable options for patients paying out-of-pocket and to counter the growing market of compounded versions of weight-loss drugs. Eli Lilly has unveiled 7.5 mg and 10 mg single-dose vials of Zepbound, each priced at $499 for a months supply when refilled within 45 days through Lillys new Zepbound Self Pay Journey Program available on its direct-to-consumer website LillyDirect